Access Resources
1401 - 1450 of 7540 Results
Title
Year
- Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease2022RESTRICTEDTitle: Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 6Start Page: 592End Page: 592Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0676Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016616Citation Count: 27
-
RESTRICTEDTitle: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 62End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002Citation Count: 2
-
RESTRICTEDTitle: Emerging roles of endoplasmic reticulum proteostasis in brain developmentJournal Name: Cells & DevelopmentPublisher: Elsevier BVVol: 170Issue #:Start Page: 203781End Page: 203781Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cdev.2022.203781Best OA location URL: https://doi.org/10.1016/j.cdev.2022.203781Citation Count: 4
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting2022RESTRICTEDTitle: Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international settingJournal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 6Start Page: e049530End Page: e049530Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2021-049530Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/6/e049530.full.pdfCitation Count: 2
- Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes2022RESTRICTEDTitle: Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 167Issue #:Start Page: 105668End Page: 105668Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105668Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105668Citation Count: 11
-
RESTRICTEDTitle: Glucose-lowering drugs, cognition, and dementia: The clinical evidenceJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 137Issue #:Start Page: 104654End Page: 104654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104654Best OA location URL: http://manuscript.elsevier.com/S0149763422001439/pdf/S0149763422001439.pdfCitation Count: 6
-
RESTRICTEDTitle: Group Exercise Classes Are Fun and MotivatingJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834396.10260.d4Citation Count: 0
-
RESTRICTEDTitle: How Flavonoids Affect Parkinson's DiseaseJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834392.64279.cfCitation Count: 0
-
RESTRICTEDTitle: Immune responses in the Parkinson's disease brainJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105700End Page: 105700Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105700Citation Count: 27
- Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease2022RESTRICTEDTitle: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s diseaseJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 3Issue #: 2Start Page: 101445End Page: 101445Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445Best OA location URL: https://doi.org/10.1016/j.xpro.2022.101445Citation Count: 0
-
RESTRICTEDTitle: Issue OverviewJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75Citation Count: 0
- Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease2022RESTRICTEDTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: http://www.cell.com/article/S216225312200035X/pdfCitation Count: 9
-
RESTRICTEDTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 0
-
RESTRICTEDTitle: Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-SynucleinopathiesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 11Start Page: 6216End Page: 6216Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23116216Best OA location URL: https://www.mdpi.com/1422-0067/23/11/6216/pdf?version=1654589185Citation Count: 24
-
RESTRICTEDTitle: Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacementJournal Name: iSciencePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 104476End Page: 104476Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2022.104476Best OA location URL: http://www.cell.com/article/S2589004222007477/pdfCitation Count: 13
- Perry Syndrome with Intrafamilial Heterogeneity in Presentation and Survival Including Acute Respiratory Failure: Case Series2022RESTRICTEDTitle: Perry Syndrome with Intrafamilial Heterogeneity in Presentation and Survival Including Acute Respiratory Failure: Case SeriesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 816End Page: 820Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13473Best OA location URL: https://doi.org/10.1002/mdc3.13473Citation Count: 2
-
RESTRICTEDTitle: Pets May Be Good for Brain HealthJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 6End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834384.40968.7eCitation Count: 0
- Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients2022RESTRICTEDTitle: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patientsJournal Name: Clinical and Translational DiscoveryPublisher: WileyVol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/ctd2.96Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctd2.96Citation Count: 4
-
RESTRICTEDTitle: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 6Start Page: 100661End Page: 100661Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245058Citation Count: 45
- Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial2022RESTRICTEDTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 26
-
RESTRICTED
- The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability2022RESTRICTEDTitle: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityJournal Name: CellPublisher: Elsevier BVVol: 185Issue #: 12Start Page: 2035End Page: 2056.e33Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008Best OA location URL: http://www.cell.com/article/S009286742200592X/pdfCitation Count: 48
-
RESTRICTEDTitle: The Regulation of ImmunityJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 208Issue #: 11Start Page: 2450End Page: 2455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.2290007Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/208/11/2450/1501657/ji2290007.pdfCitation Count: 0
- The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease2022RESTRICTEDTitle: The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105687End Page: 105687Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105687Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105687Citation Count: 13
- Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease2022RESTRICTEDTitle: Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200113Best OA location URL: https://n.neurology.org/content/neurology/98/22/e2194.full.pdfCitation Count: 17
- Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study2022RESTRICTEDTitle: Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 751End Page: 758Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13471Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13471Citation Count: 9
-
RESTRICTEDTitle: GBA-associated PD: chances and obstacles for targeted treatment strategiesJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 129Issue #: 9Start Page: 1219End Page: 1233Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-022-02511-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-022-02511-7.pdfCitation Count: 23
-
RESTRICTEDTitle: Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 6Start Page: 2077End Page: 2091Publication Date:Open Access(OA) Status: RESTRICTEDLicense: public-domainDOI - Digital Object Identifier: 10.1093/brain/awab456Best OA location URL: https://academic.oup.com/brain/article-pdf/145/6/2077/45614432/awab456.pdfCitation Count: 25
- Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson’s disease patients2022RESTRICTEDTitle: Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson’s disease patientsJournal Name: International Journal of NeurosciencePublisher: Informa UK LimitedVol: 133Issue #: 12Start Page: 1319End Page: 1325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/00207454.2022.2079501Citation Count: 3
- Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in Humans2022RESTRICTEDTitle: Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in HumansJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 87Issue #: 3Start Page: 1251End Page: 1290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-220071Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268955Citation Count: 8
-
RESTRICTEDTitle: Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral SclerosisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1756End Page: 1761Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29079Citation Count: 3
-
RESTRICTEDTitle: Quality of Life for Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741Best OA location URL: https://n.neurology.org/content/neurology/98/22/e2293.full.pdfCitation Count: 1
-
RESTRICTEDTitle: Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive statusJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 9Start Page: 5251End Page: 5258Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06129-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06129-1.pdfCitation Count: 0
-
RESTRICTEDTitle: Heart-brain synchronization breakdown in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00323-wBest OA location URL: https://www.nature.com/articles/s41531-022-00323-w.pdfCitation Count: 1
-
RESTRICTEDTitle: Immune Senescence, Immunosenescence and AgingJournal Name: Frontiers in AgingPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fragi.2022.900028Best OA location URL: https://www.frontiersin.org/articles/10.3389/fragi.2022.900028/pdfCitation Count: 48
- Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementia2022RESTRICTEDTitle: Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementiaJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 1Issue #: 1Start Page: 223End Page: 225Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/27694127.2022.2076770Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2022.2076770?needAccess=trueCitation Count: 2
- Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative2022RESTRICTEDTitle: Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 37Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/gps.5727Best OA location URL: https://psyarxiv.com/rxqev/downloadCitation Count: 3
- Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s disease2022RESTRICTEDTitle: Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.75126Best OA location URL: https://doi.org/10.7554/elife.75126Citation Count: 29
-
OPENTitle: Elucidating the importance and regulation of key enhancers for human MEIS1 expressionJournal Name: LeukemiaPublisher: Springer Science and Business Media LLCVol: 36Issue #: 8Start Page: 1980End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41375-022-01602-4Best OA location URL: https://www.nature.com/articles/s41375-022-01602-4.pdfCitation Count: 3
-
RESTRICTEDTitle: Genome-wide analysis furthers decoding of Alzheimer disease geneticsJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 7Start Page: 387End Page: 388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-022-00678-xCitation Count: 7
-
RESTRICTEDTitle: Corticobasal Syndrome with TAR Binding Protein 43–Positive Oligodendrocyte InclusionsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1564End Page: 1565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29070Citation Count: 0
- Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging features2022RESTRICTEDTitle: Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging featuresJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5Start Page: 2188End Page: 2198Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-022-00688-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-022-00688-9.pdfCitation Count: 11
-
RESTRICTEDTitle: Intracellular Aβ42 Aggregation Leads to Cellular ThermogenesisJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 144Issue #: 22Start Page: 10034End Page: 10041Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/jacs.2c03599Best OA location URL: https://www.repository.cam.ac.uk/bitstreams/2ebb814e-3b56-4c26-8129-80dd0e93e171/downloadCitation Count: 16
- The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans2022RESTRICTEDTitle: The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged HumansJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.902191Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.902191/pdfCitation Count: 3
-
RESTRICTEDTitle: Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late StageJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1654End Page: 1662Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29062Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810258Citation Count: 18
- Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants2022RESTRICTEDTitle: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein VariantsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1790End Page: 1804Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00190Citation Count: 2
- The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models2022RESTRICTEDTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 2
-
RESTRICTEDTitle: The Role of Ubiquitin in Regulating Stress Granule DynamicsJournal Name: Frontiers in PhysiologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphys.2022.910759Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphys.2022.910759/pdfCitation Count: 10
- Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease2022RESTRICTEDTitle: Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 4Start Page: 1155End Page: 1167Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-212989Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934950Citation Count: 9
-
RESTRICTEDTitle: Automatic Facial Asymmetry Analysis for Elderly Stroke Detection by using Cosine SimilarityJournal Name: 2022 19th International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/ecti-con54298.2022.9795508Citation Count: 1